Cadila Healthcare informs about press release

21 Dec 2017 Evaluate

Cadila Healthcare has informed about press release titled ‘Zydus receives final approval from the USFDA for Nifedipine Extended-Release Tablets USP’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

925.95 -10.35 (-1.11%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.